Peter Rahmer - 28 Oct 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
28 Oct 2025
Net transactions value
-$299,949
Form type
4
Filing time
30 Oct 2025, 16:19:46 UTC
Previous filing
30 Jul 2025
Next filing
15 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rahmer Peter Chief Corporate Development Officer; Exhibit 24 - Power of Attorney C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Soo-Yeun Lim, as Attorney-in-Fact 30 Oct 2025 0001959229

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $139,494 -19,135 -5.1% $7.29 358,863 28 Oct 2025 Direct F1, F2
transaction RLAY Common Stock Sale $160,455 -21,394 -6% $7.50 337,469 29 Oct 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 47,897 shares of restricted stock units ("RSUs") on October 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 108,919 shares underlying RSUs.
F3 This transaction was executed in multiple trades at prices ranging from $7.49 to $7.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Chief Corporate Development Officer; Exhibit 24 - Power of Attorney